NFKB1 and diabetic kidney disease: TLR4 and the complement system are widely involved in the occurrence and progression of various diseases, such as renal IRI, AKI and diabetic nephropathy [36–38], which can activate the transcription and expression of NFκB-mediated complement factor, thereby initiating the inflammatory cascade [39, 40].